Reported about 10 hours ago
Investors are raising concerns about CoreWeave's planned $9 billion acquisition of Core Scientific, with a key proxy advisor recommending shareholders reject the deal. Core Scientific's stock has gained value as the market perceives its worth exceeds the acquisition offer. A shareholder vote takes place on October 30, and the outcome could reflect investor confidence in AI-related investments.
Source: YAHOO